Table 1 Characteristics of nasopharyngeal carcinoma patients with stage II-IVB
| Â | ICRT arm (%) | ICCCRT arm (%) | P-value |
|---|---|---|---|
Age (years) | Â | Â | 0.55 |
 ≤ 54 years | 69 (49.64) | 42 (53.85) |  |
 > 54 years | 70 (50.36) | 36 (46.15) |  |
Sex | Â | Â | 0.66 |
 Male | 105 (75.54) | 61 (78.21) |  |
 Female | 34 (24.46) | 17 (21.79) |  |
T category | Â | Â | 0.21 |
 T1 | 61 (43.88) | 33 (42.31) |  |
 T2 | 43 (30.94) | 16 (20.51) |  |
 T3 | 20 (14.39) | 16 (20.51) |  |
 T4 | 15 (10.79) | 13 (16.67) |  |
N category | Â | Â | 0.19 |
 N0 | 7 (5.04) | 3 (3.85) |  |
 N1 | 47 (33.81) | 19 (24.36) |  |
 N2 | 74 (53.24) | 53 (67.95) |  |
 N3 | 11 (7.91) | 3 (3.85) |  |
Clinical stage | Â | Â | 0.13 |
 II | 46 (33.09) | 18 (23.08) |  |
 III | 69 (49.64) | 44 (56.41) |  |
 IVA | 13 (9.35) | 13 (16.67) |  |
 IVB | 11 (7.91) | 3 (3.85) |  |
IC regimen | Â | Â | 0.11 |
 FP | 16 (11.51) | 13 (16.67) |  |
 TP | 106 (76.26) | 49 (62.82) |  |
 other | 17 (12.23) | 16 (20.51) |  |
IC cycles | Â | Â | 0.78 |
 ≤ 2 cycles | 81 (58.27) | 47 (60.26) |  |
 > 2 cycles | 58 (41.73) | 31 (39.74) |  |